1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6C2BE7CEE7652220900258BB1002B6E9F
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-medical-affairs-product-launch-in-respiratory-timelines-resources-success-factors-digital-influence?opendocument
18
19opendocument
2018.97.9.168
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Launch Optimization

Medical Affairs Product Launch in Respiratory: Timelines, Resources, Success Factors, and Digital Influence

ID: 5832


Features:

7 Info Graphics

18 Data Graphics

340+ Metrics


Pages/Slides: 34


Published: 2024


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Medical Affairs Product Launch in Respiratory: Timelines, Resources, Success Factors, and Digital Influence”

STUDY OVERVIEW

In respiratory product launches, success hinges on well-managed timelines, resource deployment, and digital innovation. Medical Affairs teams play a critical role in aligning these aspects with both clinical evidence and market needs.


Best Practices, LLC undertook this benchmarking research to delve into the key aspects of respiratory product launch preparedness, including timeline management, resource allocation, and digital strategies. The study also examines the key success factors and challenges that Medical Affairs teams must navigate to lead high-impact product launches that resonate with both healthcare professionals and patients.

KEY TOPICS

  • Respiratory Launch Timelines, Preparedness Metrics, and Resourcing
  • Critical Success Factors and Major Pitfalls for Medical Affairs During Respiratory Launches
  • Digital Influence on Respiratory Launch Processes and Launch Tool Deployment

KEY METRICS

  • Respiratory launch activities timeline for Medical Affairs
  • Medical Affairs launch staffing and budget per respiratory product
  • Launch dashboard and performance tracking for respiratory products
  • Medical Affairs’ pre and post launch budget allocation in respiratory
  • Medical Affairs’ pre and post launch staffing allocation in respiratory
  • Key success factors for Medical Affairs in respiratory launches
  • Major challenges encountered by Medical Affairs during respiratory launches
  • Post-pandemic digital technology utilization during respiratory product launches
  • Digital launch tool deployment by Medical Affairs throughout the respiratory launch process
  • Influence of digital activities and programs that Medical leads and supports in respiratory
  • High-impact digital tools for Medical Affairs’ respiratory launch activities

SAMPLE KEY FINDINGS

  • Launch Tool Deployment: Respiratory segment participants typically kick off digital activities one phase later than when they should ideally start, according to their own standards. The widest gap occurs in actual committee / promotional engagement time vs. ideal.

METHODOLOGY

This benchmarking study engaged 20 Medical leaders from 16 leading life sciences organizations. The study insights are drawn primarily from Medical Directors and upper management executives, representing nearly 80% of the benchmark class.

Industries Profiled:
Pharmaceutical; Biotech; Diagnostic; Chemical; Health Care; Biopharmaceutical; Consulting; Consumer Products


Companies Profiled:
AstraZeneca; BELLUS Health; BIAL; bioMerieux; Boehringer Ingelheim; Cipla; Eurofarma; Genentech; Grünenthal; Labaid Group; Matinas BioPharma; MEDiSTRAVA; Novartis; Sandoz; Sunovion; Vertex Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.